These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 11801555

  • 1. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C.
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [Abstract] [Full Text] [Related]

  • 2. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I, Scher HI, Zhang ZF, Pellicer I, Hamza R, Eissa S, Khaled H, Cordon-Cardo C.
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R, Pezzella F, Gatter K, Algara P, Sánchez-Beato M, Martínez P, Martínez JC, Muñoz K, García P, Sánchez L, Kocialkowsky S, Campo E, Orradre JL, Piris MA.
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [Abstract] [Full Text] [Related]

  • 5. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM.
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [Abstract] [Full Text] [Related]

  • 8. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
    Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R.
    J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma.
    Ito K, Sasano H, Matsunaga G, Sato S, Yajima A, Nasim S, Garret CT.
    J Pathol; 1997 Nov; 183(3):318-24. PubMed ID: 9422988
    [Abstract] [Full Text] [Related]

  • 14. p53 and MDM2 in the development and progression of bladder cancer.
    Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T, Ackermann R.
    Eur Urol; 1997 Nov; 32(4):487-93. PubMed ID: 9412812
    [Abstract] [Full Text] [Related]

  • 15. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
    García JF, Piris MA, Lloret E, Orradre JL, Murillo PG, Martínez JC.
    Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, Berkowitz RS.
    J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.
    Olsson H, Hultman P, Rosell J, Söderkvist P, Jahnson S.
    BMC Urol; 2013 Jan 28; 13():5. PubMed ID: 23356517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.